Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot, Open-label, Multicenter Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease

NCT01791686 is registered in ClinicalTrials.gov with Celldex Therapeutics as lead sponsor.

NCT NCT01791686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01791686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot, Open-label, Multicenter Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
Lead sponsor
Celldex Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2013
Completion date
March 31, 2014
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

c3 glomerulonephritis, dense deposit disease, membranoproliferative glomerulonephritis type ii